• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
ThromboGenics Announces FDA Acceptance of Investigational New
ThromboGenics Announces FDA Acceptance of Investigational New

... JETREA was evaluated in two multi-center, randomized, double-masked Phase III trials conducted in the U.S. and Europe involving 652 patients with vitreomacular adhesion. Both studies met the primary endpoint of resolution of VMA at day 28. This Phase III program found that 26.5% of patients treated ...
Volume 4, Issue 2 - Outcome Resources
Volume 4, Issue 2 - Outcome Resources

... hospice patients. On April 9th, bowing to intense pressure from a coalition of hospice & palliative care organizations, pharmacy associations, and physician groups, the FDA partially reversed its decision to force a suspension of the production of concentrated oral morphine 20mg/ml solution. The FDA ...
The DRESS Syndrome  Introduction
The DRESS Syndrome Introduction

... withdrawal and corticosteroid therapy. It was then realized that this syndrome can be fatal. Numerous drugs can be responsible for this reaction to medication. In 2004 the authors reported the case of a 11-year-old girl hospitalized with an acute severe hepatitis revealing an oxcarbazepine-induced ...
Introduction to Medical Genetics
Introduction to Medical Genetics

... The most common yet still the least understood of human genetic diseases ...
File
File

PPTX - Interfaces.com
PPTX - Interfaces.com

... Auranofin causes reactive oxygen-mediated parasite killing ...
Psychiatric Disorders and Medications During Pregnancy and the
Psychiatric Disorders and Medications During Pregnancy and the

... nortriptyline and clomipramine are safe during breastfeeding (Becker, 2009). Doxepin is contraindicated (respiratory depression). ...
GDH-PQQ Test Strip Implementation Strategies
GDH-PQQ Test Strip Implementation Strategies

... This last item is an additional patient safety suggestion for hospitals that own GDH-PQQ devices. It is not an FDA recommendation. ...
Review Questions on Basic Pharmacology
Review Questions on Basic Pharmacology

... Review Questions on Basic Pharmacology. Make a list of your answers & then check them against the Answer Key 1. An antagonist is a type of drug that: A.has maximal efficacy B.has affinity for a receptor but little efficacy C.binds to a receptor and activates it D.has efficacy but low affinity E.decr ...
Why is it important to consider the route of
Why is it important to consider the route of

... Time to Effect of Cocaine ...
20100420 - FAMU.edu
20100420 - FAMU.edu

... third of patients are treatment-resistant (TRS) and do not benefit from the medications currently available. In addition, schizophrenia is associated with suicidal ideation and somewhere between 9-13% of patients eventually take their own lives. Even more troubling is the fact that 65 to 80 % of out ...
biological treatments for schizophrenia gapfill
biological treatments for schizophrenia gapfill

... C............................... antipsychotics are more commonly administered and .................................. antipsychotics were later developed which are believed to be more effective but more expensive. Chlorpromazine is a common conventional antipsychotic which combats the positive sympt ...
Managing poisoning or overdose
Managing poisoning or overdose

... test before administering. Use only in patients in shock or cardiac arrest with ventricular arrhythmias, such as ventricular tachycardia or fibrillation; with progressive bradycardia, such as severe sinus bradycardia; or with second– or third-degree atrioventricular block unresponsive to atropine. I ...
gtbtn07USA229
gtbtn07USA229

... The new labelling would be required for all OTC drug products containing an IAAA active ingredient whether marketed under an OTC drug monograph or an approved new drug application (NDA). FDA is issuing this proposal as part of its ongoing review of OTC drug products after considering the advice of i ...
Copper-promoted C-X bonc cross-coupling via boronic acids: Chan
Copper-promoted C-X bonc cross-coupling via boronic acids: Chan

... need for novel antithrombotics with an improved safety profile to replace Warfarin which has been in use for ~60 years and has significant bleeding issues. Factor Xa is at the junction of the intrinsic and extrinsic pathways of the coagulation cascade. Preclinical data has demonstrated that blocking ...
Microevolution is a change in a population*s gene pool
Microevolution is a change in a population*s gene pool

... Microevolution is a change in a population’s gene pool ...
Impacts of Antimalarial Campaigns on Plasmodium falciparum
Impacts of Antimalarial Campaigns on Plasmodium falciparum

... parasite samples, used qPCR to identify positive samples, and amplified five microsatellite loci for our microsatellite genotyping which will later be used for population comparisons. From current data from our lowland site, we have identified allelic variations in the lowland site with four present ...
surprising truths about opioid misuse
surprising truths about opioid misuse

... performed often depends on whether a physician believes a patient needs testing. However, most healthcare providers are not skilled at identifying high-risk patients on their own.4 Consequently, physicians sometimes test every patient at every visit, even when initial test results have been consiste ...
Equine Medications, Forney, 2001
Equine Medications, Forney, 2001

... • November, 2008: Formed a commission on medication and doping – Examine current drug policy and testing procedures • Make sure they conform to World Anti-Doping Agency (WADA) guidelines ...
Vol. 32, No. 2 Drug Interactions between Oral
Vol. 32, No. 2 Drug Interactions between Oral

... negatively impact the success of tamoxifen treatment. Antidepressants are commonly used to treat depression and/or vasomotor symptoms in women with breast cancer. Hot flashes, in particular, are a well-documented side effect of tamoxifen therapy and a common symptom experienced by menopausal women. ...
Section: 2-1
Section: 2-1

Analysing the Investigational New Drug (IND) Application IND
Analysing the Investigational New Drug (IND) Application IND

... indicated Use Š No commercial distribution or test marketing Š No prolongation of study Š Prior written approval from FDA required to “charge”  for drug, unless being used under “treatment” IND ...
Drug Classes for Hig..
Drug Classes for Hig..

... • Drugs from 11 major classes have been approved by the United States Food and Drug Administration to treat hypertension • Many of these drugs have complementary effects to reduce blood pressure and prevent target organ damage • The goal of antihypertensive therapy is to use doses of drugs that effe ...
Clinical Analysis of Adverse Drug Reactions
Clinical Analysis of Adverse Drug Reactions

...  estimates of incidence vary with study methods, population, and ADR definition  4th to 6th leading cause of death among hospitalized patients*  6.7% incidence of serious ADRs*  0.3% to 7% of all hospital admissions  annual dollar costs in the billions  30% to 60% are preventable ...
Immune Functions of B Cells
Immune Functions of B Cells

... Genetic Risk Factors are Stronger Predictors of Developing Infections (UTIs) than Clinical Risk Factors Etanercept vs Methotrexate in the Early RA Etanercept Trial ...
< 1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report